FLYLF yields 825.08% · MRK yields 2.81%● Live data
📍 FLYLF pulled ahead of the other in Year 1
Combined, FLYLF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FLYLF + MRK for your $10,000?
FLYHT Aerospace Solutions Ltd. provides real-time communications with aircrafts for the aerospace industry. It offers AFIRS, an automated flight information reporting system that is a satcom aircraft interface device, which enables real-time streaming of flight information, cockpit voice, and black box data streaming; TAMDAR, a tropospheric airborne meteorological data reporting system that aggregates and streams airborne weather data in real-time; AirMap, which provides real-time monitoring and insight of fleets; and UpTime, a ground-based, enterprise server that communicates with AFIRS through satellite connectivity and serves its customers with real-time applications. The company also offers FLYHTStream, a technology that performs real-time triggered alerting and black-box data streaming in the event of an abnormal situation in aircraft; FLYHTLog, which enables operators to monitor the status of their aircraft and have detailed out, off, on, and in time information; FLYHTVoice, a private communication channel for flight deck; and FLYHTMail, a two-way text messaging system for the flight crew and dispatch personnel. In addition, it provides aircraft health monitoring and automated engine trend reporting systems; and FLYHT Weather Observations that offers real-time weather data. It serves in the United States, Mexico, Asia, China, the Middle East, Canada, Australia, Africa, Europe, and South/Central America. The company was formerly known as AeroMechanical Services Ltd. and changed its name to FLYHT Aerospace Solutions Ltd. in May 2012. FLYHT Aerospace Solutions Ltd. was founded in 1998 and is headquartered in Calgary, Canada.
Full FLYLF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.